CAPTRUST Financial Advisors’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Buy |
12,613
+526
| +4% | +$19K | ﹤0.01% | 1790 |
|
|
2025
Q1 | $376K | Sell |
12,087
-2,742
| -18% | -$85.4K | ﹤0.01% | 1813 |
|
|
2024
Q4 | $378K | Sell |
14,829
-14,499
| -49% | -$370K | ﹤0.01% | 1769 |
|
|
2024
Q3 | $830K | Sell |
29,328
-1,596
| -5% | -$45.2K | ﹤0.01% | 1296 |
|
|
2024
Q2 | $815K | Sell |
30,924
-2,535
| -8% | -$66.8K | ﹤0.01% | 1250 |
|
|
2024
Q1 | $1.02M | Sell |
33,459
-5,589
| -14% | -$170K | ﹤0.01% | 1118 |
|
|
2023
Q4 | $1.1M | Sell |
39,048
-17,872
| -31% | -$502K | ﹤0.01% | 1192 |
|
|
2023
Q3 | $1.54M | Sell |
56,920
-4,745
| -8% | -$129K | 0.01% | 968 |
|
|
2023
Q2 | $1.9M | Buy |
61,665
+26
| +0% | +$799 | 0.01% | 853 |
|
|
2023
Q1 | $2.22M | Sell |
61,639
-3,999
| -6% | -$144K | 0.01% | 710 |
|
|
2022
Q4 | $2.59M | Buy |
65,638
+1,484
| +2% | +$58.6K | 0.01% | 630 |
|
|
2022
Q3 | $2.58M | Buy |
64,154
+63,866
| +22,176% | +$2.57M | 0.02% | 588 |
|
|
2022
Q2 | $12K | Buy |
288
+29
| +11% | +$1.21K | ﹤0.01% | 3662 |
|
|
2022
Q1 | $10K | Buy |
259
+112
| +76% | +$4.32K | ﹤0.01% | 3814 |
|
|
2021
Q4 | $6K | Sell |
147
-60
| -29% | -$2.45K | ﹤0.01% | 4000 |
|
|
2021
Q3 | $7K | Buy |
207
+200
| +2,857% | +$6.76K | ﹤0.01% | 3818 |
|
|
2021
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 4635 |
|